Active Motif (United States)

Recent papers from Active Motif (United States)

1. The majority of 5hmC is nucleosome-associated in naïve B cellsBMC Genomics · 2026
2. What matters in next-generation implanted neurotechnology design? Perspectives from individuals with treatment-refractory depressionJournal of Neural Engineering · 2026
3. Trained immunity links hematopoietic stem cell aging to aging-associated inflammationNature Aging · 2026
4. Model-based design and placement analysis for epidural cortical stimulationJournal of Neural Engineering · 2026
5. Abstract 1932: TIP-ChIP: Tagmented, indexed and pooled ChIP-seq to generate high-throughput, multi-sample results for low input samples.Cancer Research · 2026
6. KDM5 demethylases suppress R-loop-mediated ‘viral mimicry’ and DNA damage in breast cancer cellseLife · 2025
7. KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells2025
8. MNase stratification reveals heterogeneous 5hmC in naive B cells2025
9. Genetic mapping for agronomic, nutritional, and leaf vein traits in the indigenous crop Gynandropsis gynandraSocio-Environmental Systems Modeling · 2025
10. KDM5 demethylases suppress R-loop-mediated ‘viral mimicry’ and DNA damage in breast cancer cellseLife · 2025
11. KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cellseLife · 2025
12. KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells2025
13. What do patients with lumbar spinal stenosis think is physical therapy’s best card? A survey of perceived message strengthJournal of Manual & Manipulative Therapy · 2024
14. Miniature battery-free epidural cortical stimulatorsScience Advances · 2024
15. Abstract 1742: A universal spike-in normalization strategy for CUT&RUN, CUT&Tag and ATAC-seqCancer Research · 2024
16. Abstract 4415: Utilization of MBD-seq to elucidate differentially methylated regions in cfDNA across healthy and cancer patientsCancer Research · 2024
17. Abstract 332: Improved high-throughput genomic analysis of urine samples using pixelated-ultrasound to enable personalized genomic profiling and therapeutic developments in cancerCancer Research · 2024
18. Abstract 3099: A new HTS ELISA for monitoring NRAS activity to expedite drug discoveryCancer Research · 2024
19. BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitorBlood · 2024
20. 25.3 Toward Exponential Growth of Therapeutic Neurotechnology2024